logo

Skye Bioscience Inc (SKYE) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Skye Bioscience Inc’s current trading price is -83.46% away from its 52-week high, while its distance from the 52-week low is 38.96%. The stock’s price range during this period has varied between $2.31 and $19.41. The company, active in the Healthcare sector, saw a trading volume of around 0.51 million for the day, considerably higher average daily volume of 0.18 million observed over the last three months.

Skye Bioscience Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $19.41 on 03/04/24, with the lowest value being $2.31 on 12/30/24.

How Financial Performance Impacts Market Capitalization

Skye Bioscience Inc (SKYE) has experienced a quarterly decline of -38.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 97.39M and boasts a workforce of 11 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.05, with a change in price of -2.63. Similarly, Skye Bioscience Inc recorded 278,242 in trading volume during the last 100 days, posting a change of -45.03%.

How SKYE’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SKYE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

SKYE Stock Stochastic Average

As of today, the raw stochastic average of Skye Bioscience Inc over the past 50 days is 32.26%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 44.97%. Additionally, the Stochastic %K and %D values for the company were 76.06% and 68.36%, respectively, over the past 20 days.

SKYE Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 13.43% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -37.91%. Over the past 30 days, the price of SKYE has fallen by 25.88%. And in the last five days, it has surged by 15.47%.

Most Popular